Ignite Creation Date:
2025-12-24 @ 9:41 PM
Ignite Modification Date:
2025-12-25 @ 7:23 PM
Study NCT ID:
NCT02153632
Status:
TERMINATED
Last Update Posted:
2022-02-16
First Post:
2014-05-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
Sponsor:
Adamas Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05-20
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-30
First Submit QC Date:
None
Study First Post Date:
2014-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-21
Results First Submit QC Date:
None
Results First Post Date:
2019-04-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-14
Last Update Post Date:
2022-02-16
Last Update Post Date Type:
ACTUAL